Use of the CDR® plus NACC FTLD in mild FTLD: Data from the ARTFL/LEFFTDS consortium-Reference-Cited by-同舟云学术

Use of the CDR® plus NACC FTLD in mild FTLD: Data from the ARTFL/LEFFTDS consortium

Published:2020-01 Issue:1 Volume:16 Page:79-90
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's Dement.

Author:

Miyagawa Toji¹,Brushaber Danielle¹,Syrjanen Jeremy¹,Kremers Walter¹,Fields Julie¹,Forsberg Leah K.¹,Heuer Hilary W.²,Knopman David¹,Kornak John²,Boxer Adam²,Rosen Howie²,Boeve Bradley¹,

Affiliation:

1. Mayo Clinic; Rochester MN USA

2. UCSF; San Francisco CA USA

Funder

National Institutes of Health

Centers for Disease Control and Prevention

Bristol-Myers Squibb

Avid Radiopharmaceuticals

Janssen Immunotherapy

Novartis

Pfizer

Wyeth

SNIFF

Tau Consortium

Frontotemporal Dementia

Huntington's Disease Society of America

New York State Department of Health

Biogen

TauRx

AbbVie

Eli Lilly and Company

AstraZeneca

Eli Lilly

Roche

Genentech

Canadian Institutes of Health Research

Alzheimer Society of B.C.

BrightFocus Foundation

Penn Institute on Aging

Alzheimer's Drug Discovery Foundation

Avid

Eisai

University of California, San Francisco

Parkinson Study Group

Parkinsonfonden

Michael J. Fox Foundation for Parkinson's Research

AVID Pharmaceuticals

Allon Therapeutics

C2N Diagnostics

Eisai Inc.

Janssen Pharmaceuticals

Medivation

Merck

Navidea Biopharmaceuticals

TauRx Therapeutics

Jane Tanger Black

Young-Onset Dementias

Alzheimer's Association

Alector

Allergan, Inc

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1016/j.jalz.2019.05.013/fullpdf

Reference30 articles.

1. A new clinical scale for the staging of dementia;Hughes;Br J Psychiatry,1982

2. The Clinical Dementia Rating (CDR): current version and scoring rules;Morris;Neurology,1993

3. Development of methodology for conducting clinical trials in frontotemporal lobar degeneration;Knopman;Brain,2008

4. The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers;Morris;Alzheimer Dis Assoc Disord,2006

5. Language and behavior domains enhance the value of the clinical dementia rating scale;Knopman;Alzheimers Dement,2011

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of Care Home Admission and Survival Rate in Patients With Syndromes Associated With Frontotemporal Lobar Degeneration in Europe;Neurology;2024-10-08

2. Cognitive dispersion and its functional relevance in behavioral variant frontotemporal dementia and prodromal behavioral variant frontotemporal dementia.;Neuropsychology;2024-08-29

3. Impairments in knowledge of social norms in presymptomatic, prodromal, and symptomatic frontotemporal dementia;Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring;2024-07

4. Sex Differences in the Severity and Progression of Neuropsychiatric Symptoms Across Different Dementia Types;Neurology Clinical Practice;2024-06

5. Non-motor symptoms in patients with amyotrophic lateral sclerosis: current state and future directions;Journal of Neurology;2024-05-28